Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1204 participants
OBSERVATIONAL
2009-08-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, death and heart failure incidence after STEMI remain elevated: up to 20% at one year.
Also, therapeutic management following international guidelines is standardized toward a "one-size fits all" therapeutic management.
In order to continue improving myocardial infarction outcomes, there is a need to better understand and individualize therapeutic targets such myocardial reperfusion injury, post reperfusion inflammation, adverse left ventricular (LV) remodeling ….
This knowledge will allow us to propose new therapeutic strategies and in the long run strive towards personalized medicine.
The aim objective of this cohort of STEMI patients is to identify new biological markers of injury and prognosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Cohort of STEMI Patients
NCT03070496
Evaluation of Soluble ST2 in Patients Receiving Primary PCI With ST-elevation Myocardial Infarction
NCT02830217
Quality and Safety of Initial Management for ST-segment Elevation Myocardial Infarction
NCT02788344
The Short- and Long Term Outcomes of Early Routine PCI With the Standard Treatment in Low-intermediate Risk ST-elevation Myocardial Infarction Patients Who Successfully Fibrinolysis.
NCT02131103
Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction
NCT02164695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
STEMI PATIENT Cohort
STEMI PATIENT Cohort
STEMI PATIENT Cohort
PCI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
STEMI PATIENT Cohort
PCI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of STEMI defined by ST segment elevation ≥ 0.2 mV in 2 contiguous leads on a 12-lead ECG.
* Primary PCI within 12 hours of symptoms onset.
Exclusion Criteria
* Refusal to participate in the study or to sign the consent
* Inability to give information to the subject about the study
* Lack of medical social coverage
* Deprivation of civil rights
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel OVIZE, Pr
Role: PRINCIPAL_INVESTIGATOR
Centre d'investigation Clinique , Hôpital Cardiovasculaire Louis Pradel 28, Avenue du Doyen Lépine - 69677 BRON
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Cardiovasculaire Louis Pradel 28, Avenue du Doyen Lépine
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL16_0412
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.